Mechanism of Action: Dual-Pathway Stimulation

In research protocols, this blend is studied for its ability to maximize the amplitude of growth hormone (GH) pulses. The two compounds work via distinct but complementary pathways:

CJC-1295 (No DAC): Functions as a GHRH mimetic. It binds to GHRH receptors in the anterior pituitary to initiate the production and release of growth hormone. The “No DAC” (Drug Affinity Complex) version is specifically chosen for its shorter half-life, more closely mimicking the natural physiological spikes of human GH.

Ipamorelin: Acts as a selective Ghrelin receptor agonist. It reinforces the GH pulse by inhibiting somatostatin (the hormone that suppresses GH) and directly stimulating the pituitary to release stored GH.

Key Research Focus Areas:

Hypertrophic Signaling: Investigation into the upregulation of IGF-1 and its role in cellular repair, muscle protein synthesis, and bone density.

Metabolic Efficiency: Researching the blend’s impact on basal metabolic rate, adipose tissue oxidation, and nitrogen retention.

Selective Potency: Unlike older secretagogues, Ipamorelin is highly selective; studies suggest it does not significantly impact prolactin, cortisol, or ACTH levels, making it a preferred subject for clean signaling research.

Recovery and Sleep Architecture: Evaluation of how pulsatile GH release influences circadian rhythm and deep-wave sleep recovery cycles.

USA Purity Verification:

Precision and consistency are the cornerstones of valid scientific research. At KareTides, every batch of CJC1295 + Ipamorelin Blend undergoes a rigorous, independent third-party High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) testing within the USA. We guarantee a purity level exceeding 99%, ensuring your laboratory receives a compound that is reliable for accurate, reproducible experimental data.

Certificate of Analysis:

10MG

CJC1295 + Ipamorelin Blend (No DAC)

Ipamorelin

Sermorelin

Tesamorelin

Do you have any questions?